A QUICK INTRODUCTION
When it comes to ensuring you get the most reliable and result-driven gefitinib manufacturer, Enanti Labs is always at the forefront.
We are a major pharmaceutical manufacturer incorporated in 2007 and our focus is on the production of high-quality Active Pharmaceutical Ingredients (APIs) and advanced intermediates to provide reliable, scalable and compliant solutions to the healthcare markets. Having the latest facilities, the high standard of quality systems and the emphasis on innovation, we guarantee that our products will be at the high level of international standards supporting the partners at the whole range of drug development and commercial production.
UNDERSTANDING GEFITINIB
Gefitinib is an oral cancer medication which is primarily used to cure some forms of non-small cell lung cancer (NSCLC). It prevents or inhibits the increase of tumours by obstructing the strange signals that lead to development of cancer cells. The Gefitinib is typically administered to individuals whose tumours contain some mutations of the EGFR gene. It is a targeted treatment and therefore can treat better and also might lower the number of side effects compared to ordinary chemotherapy.
Common uses include:
- Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC)
- First-line therapy for NSCLC patients with activating EGFR mutations
- Treatment option for patients who have previously responded to EGFR inhibitors
- Used when chemotherapy is not suitable or has been ineffective
OUR COMMITMENT: QUALITY, SCIENCE, AND PARTNERSHIP
We operate on three foundational pillars that define our corporate identity and guide every project we undertake:
Uncompromising Quality and Regulatory Excellence:
In Enanti Labs, quality is not just a checklist, but a principle that is integrated in all processes. Our highly advanced manufacturing plants meet the highest regulatory standards across the globe that encompass the GMP, ISO: 9001:2015, and the ISO 14001:2015. Each step is managed by our team including the sourcing of raw materials and their process validation through end release and distribution. It is this insatiable quality control that guarantees our partners complete confidence and security of the supply chain as every batch we manufacture is precise to the specifications.
Scientific Innovation and Technical Mastery:
Synthesis of complex APIs and intermediates is more of an art than a science. Our team of all-time chemists, engineers and technologists live on intricate molecular problems. Our investment in Research & Development is substantial to develop new synthetic pathways, streamline the current processes to make them efficient and sustainable, and increase the production volume in the laboratory and transfer it to the commercial scale without any problems.
Strategic Collaboration and Reliability:
We do not see our clients as customers, but as partners in health across the world. We know that our reliability is what determines their capability to supply therapies to market in a non-interrupted manner. We are dedicated to partnership and, therefore, provide transparent communication, versatile manufacturing, and well-developed supply chain management.
With this consideration, we have remained a leading gefitinib manufacturer in addition to a large range of APIs and Intermediates.
OUR VISION FOR THE FUTURE
The role of specialised API manufacturers is becoming increasingly important as the needs in new and more advanced treatment are increasing. We already take a lead in this evolution by engaging in green chemistry concepts to reduce our impact on the environment, investing in new technologies such as continuous manufacturing, and diversifying our portfolio towards new market areas such as oncology, biologics and complex generics.
Time to challenge the status quo – join forces with the most result-driven gefitinib manufacturer today!
Other Recommended Products: Bedaquiline Manufacturer